136 related articles for article (PubMed ID: 38619027)
1. Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.
Cocco M; Carnovale C; Clementi E; Barbieri MA; Battini V; Sessa M
Expert Rev Clin Pharmacol; 2024; 17(5-6):441-453. PubMed ID: 38619027
[TBL] [Abstract][Full Text] [Related]
2. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
3. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.
Wang X; Li L; Wang L; Feng W; Zhang P
Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829
[TBL] [Abstract][Full Text] [Related]
4. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
5. A reference set of clinically relevant adverse drug-drug interactions.
Kontsioti E; Maskell S; Dutta B; Pirmohamed M
Sci Data; 2022 Mar; 9(1):72. PubMed ID: 35246559
[TBL] [Abstract][Full Text] [Related]
6. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
[TBL] [Abstract][Full Text] [Related]
7. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
8. Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records.
Jeong E; Su Y; Li L; Chen Y
J Biomed Inform; 2024 May; 153():104639. PubMed ID: 38583580
[TBL] [Abstract][Full Text] [Related]
9. Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions.
Lu Z; Suzuki A; Wang D
BMC Med Res Methodol; 2023 Mar; 23(1):71. PubMed ID: 36973693
[TBL] [Abstract][Full Text] [Related]
10. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
[TBL] [Abstract][Full Text] [Related]
11. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.
Noguchi Y; Tachi T; Teramachi H
Pharm Res; 2020 Apr; 37(5):86. PubMed ID: 32356247
[TBL] [Abstract][Full Text] [Related]
13. Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure.
Battini V; Cocco M; Barbieri MA; Powell G; Carnovale C; Clementi E; Bate A; Sessa M
Drug Saf; 2024 Apr; ():. PubMed ID: 38687463
[TBL] [Abstract][Full Text] [Related]
14. Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug-drug interactions.
Kontsioti E; Maskell S; Pirmohamed M
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):832-844. PubMed ID: 36916014
[TBL] [Abstract][Full Text] [Related]
15. Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance.
Hauser AS; Kooistra AJ; Sverrisdóttir E; Sessa M
Expert Opin Drug Saf; 2020 Aug; 19(8):961-968. PubMed ID: 32510245
[TBL] [Abstract][Full Text] [Related]
16. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
17. An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance.
Micallef B; Dogné JM; Sultana J; Straus SMJM; Nisticò R; Serracino-Inglott A; Borg JJ
Drug Saf; 2023 Nov; 46(11):1089-1103. PubMed ID: 37707778
[TBL] [Abstract][Full Text] [Related]
18. A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.
Qian Y; Ye X; Du W; Ren J; Sun Y; Wang H; Luo B; Gao Q; Wu M; He J
Br J Clin Pharmacol; 2010 Jan; 69(1):67-73. PubMed ID: 20078614
[TBL] [Abstract][Full Text] [Related]
19. Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signalling.
Alvarez Y; Hidalgo A; Maignen F; Slattery J
Drug Saf; 2010 Jun; 33(6):475-87. PubMed ID: 20486730
[TBL] [Abstract][Full Text] [Related]
20. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.
Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N; Pariente A;
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):186-94. PubMed ID: 23670805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
